Julio E. Figueroa, II, M.D.

Bibliography

  1. 1. Figueroa JE, Oubre J, and Vijayagopal P. Modulation of vascular smooth muscle cells proteoglycan synthesis by the extracellular matrix. J Cell Physiol 2004 198(1):302-9
  2. 2. Sarria JC, Vidal AM, Kimbrough RC, Figueroa JE. Fatal infection caused by Francisella tularensis in a neutropenic bone marrow transplant recipient. Ann Hematol. 2003 Jan;82(1):41-3.
  3. 3. Figueroa JE 2nd, Vijayagopal P, Prasad C. 2002. Azaftig stimulates in vitro lipolysis by rodent and human adipocytes.Biochem Biophys Res Commun. May 3;293(2):847-9
  4. 4. Figueroa, J.E. and P. Vijayagopal. 2002. Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycan. Atherosclerosis 2002 Jun;162(2):261-8
  5. Figueroa, J.E., Z. Tao, T.G. Sarphie, F.W. Smart, D.L. Glancy, and P. Vijayagopal. 1999. Effect of hypoxia and hypoxia/reoxygenation on proteoglycan metabolism by vascular smooth muscle cells. Atherosclerosis. 143:135-144.
  6. Figueroa, J.E., P. Vijayagopal, A. Prasad, D.V. Schapira, and C. Prasad. 1999. Isolation, characterization, and distribution of a 24-kDa proteoglycan in the urine of cachectic cancer and AIDS patients. Biochem Biophys Res Commun. 254:642-646.
  7. Figueroa, J., P. Vijayagopal, C. Debata, A. Prasad, and C. Prasad. 1999. Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice. Life Sci. 64:1339-1347.
  8. Vijayagopal, P., JE Figueroa, EA Levine. "Altered composition and increased endothelial cell proliferative activity of proteoglycans isolated from breast carcinoma." J Surg Oncol 1998 Aug;68(4):250-4.
  9. Sarria JC, Chutkan NB, Figueroa JE, Hull A. "Atypical mycobacterial vertebral osteomyelitis: case report and review." Clin Infect Dis 1998 Feb;26(2):503—505
  10. Z Tao, F Smart, JE Figueroa, DL Glancy, P Vijayagopal ."Elevated expression of proteoglycans in proliferating vascular smooth muscle cells. Atherosclerosis 135: 171,1997.
  11. Tao, Z., F. Smart, J.E. Figueroa, D.L. Glancy, P. Vijayagopal. "Enhanced synthesis of proteoglycans by vascular endothelial cells treated with phorbol ester." Life Sci 1997; 61:723—38.
  12. Knoebel, E., P. Vijayagopal, J.E. Figueroa, D.H. Martin. "In vitro growth of Chlamydia pneumoniae in smooth muscle cells." Infect Immun 1997; 65:503—6
  13. Vijayagopal, P., J.E. Figueroa, J. D. Fontenot. "Characterization of a novel proteoglycan variant from human aorta exhibiting marked affinity for low density lipoprotein and its enhanced expression in atherosclerotic plaques." Atherosclerosis 1996; 127: 195—203
  14. Vijayagopal, P., J.E. Figueroa, Q. Guo, Z. Tao. "Marked alteration of proteoglycan metabolism in cholesterol—enriched human arterial smooth muscle cells." Biochem J 1996; 315 (Pt 3): 995—1000.
  15. Pallares D E. Figueroa J E. Densen P. Giclas P C. Marshall GS. Invasive Haemophilus influenzae type b infection in a child with familial deficiency of the beta subunit of the eighth component of complement. J Pediatr 1996; 128(1): 102—3.
  16. Figueroa, J. E., J. A. Andreoni and P. Densen. "Complement deficiency states and meningococcal disease." Immunologic Research. 1993; 12: 295—311.
  17. Figueroa, J. E. and P. Densen. "Infectious diseases associated with complement deficiencies." Clin Microbiol Rev. 1991; 4: 359—395

 

Non—peer—reviewed publications

1.     Bartczak J, Hagensee ME, Figueroa JE. An AIDS patient with anorexia and progressive weakness. Infect Med 19(7):305-308, 2002

2.     Kelley GP, Stellingworth MA, Mittal S, Harrison LH, Glancy DL, Figueroa J, Lopez FA. "Dyspnea in a woman infected with the human immunodeficiency virus." J La State Med Soc 153(11):529-33, 2001

3.     P. Pinnow, G. Karam, J.E. Figueroa. "An Inguinal Mass." Infect Med 18(8):375-377, 2001

4.     E. Borrero, R. Steele, J.E. Figueroa. "A Chronic Draining Elbow." Infect Med 17(12):782-786, 2000

5.     J. B. Garcia-Diaz, J. E. Figueroa, G. A. Pankey. "An Elderly Man With Fever of Unknown Origin." Infect Med 15(6):361-366, 1998.

6.     R. D. Wilcox, R. Ramphal, J.E. Figueroa. "Skin Nodules in a Neutropenic Host." Infect Med 15(8):521-523, 1998.

7.     A.A. Butt, T.F. Patterson, J.E. Figueroa. "Skin Lesions and Pulmonary Infiltrates in a Patient With AIDS." Infect Med 14(8):596—600, 1997.

8.     A.A. Butt, G.A. Pankey, J.E. Figueroa. "A Draining Chest Wall Abscess." Infect Med 14(12):935—938, 1997.

9.     C. Blais, R.Moellering, J.E. Figueroa. "A Woman With Altered Mental Status." Infect Med 15(4):224—226,229, 1998

10.   H.C. Costa, G.A. Pankey, J.E. Figueroa. "A Man From Bogalusa With Wrist Pain." Infect Med 13(6):445—446,449,522, 1996

11.   Palau LA, Figueroa JE, Pankey GA: A man from Honduras with fever and a rash. Infect Med 13(3):183—184, 189, 235, 1996.

 

Scientific presentations and abstracts.

  1. J.E. Figueroa,  R Bridges, N Causby, M Firmani. The Molecular Epidemiology of Oxacillin-Resistant Staphylococcus aureus (ORSA) Infection in New Orleans. 11th Annual International Symposium on Staphylococci & Staphylococcal Infections, 2004, Charleston, SC
  2. R Bridges, JE Figueroa, R O’Callaghan, M Firmani: Analysis of MRSA strains causing outbreaks in the Louisiana community. 104 th General Meeting of the American Society for Microbiology May 23-27, 2004, New Orleans, Louisiana
  3. G. Cauthen, J. Figueroa, K. Theall: The changing epidemiology of Gastrointestinal (GI) infections in HIV-infected individuals. Southern Society for Clinical Investigation Meeting, New Orleans February 7–9, 2004.
  4. Ewing T, Tao Z, Figueroa JE, Vijayagopal P: Effect of oxidative stress on proteoglycan synthesis by vascular endothelial cells. Southern Society for Clinical Investigation Meeting, New Orleans February 7—9, 1998.
  5. Vijayagopal P, Figueroa JE, Glancy DL: Modulation of proteoglycan synthesis by high glucose medium in human aortic smooth muscle cells generates proteoglycan variants with enhanced binding ability to low density lipoprotein. 69th Scientific sessions of the American Heart Association, New Orleans, November 10—13, 1996.
  6. Figueroa, J.E., P. Vijayagopal. "Isolation and partial characterization of a receptor for LDL—proteoglycan complex in macrophages." Southern Section, AFMR, Feb 1997
  7. Figueroa, J.E., P. Vijayagopal. "Complement—activated vascular smooth muscle cells secrete proteoglycans that have greatly increased LDL affinity." FASEB, June 1996.        
  8. Z. Tao, F.W. Smart, J. E. Figueroa, D. L. Glancy, P. Vijayagopal. "Altered proteoglycan metabolism in vascular smooth muscle cells exposed to hypoxia—reoxygenation." J Invest Med Jan 1996
  9. Vijayagopal, P., J. Figueroa, A. Gibson, Q. Guo, M. Given, T. Giles. "Angiotensin II stimulates proteoglycan synthesis by human aortic smooth muscle cells and produces a proteoglycan variant with enhanced binding ability to low density lipoprotein." Circulation 92: I—424, 1995
  10. Childs, D. B., J. E. Figueroa, and P. Vijayagopal. "Complement activation increases proteoglycan production in bovine smooth muscle cells." J Invest Med, 1995; 43: 308A
  11. Figueroa, J. E., P. Vijayagopal, and D. H. Martin. "Chlamydia pneumoniae infection of human smooth muscle cells enhances proteoglycan secretion." J Invest Med, 1995; 43: 220A
  12. Figueroa, J. E., P. Vijayagopal, D. H. Martin and D. Hall. "Chlamydia pneumoniae infection of vascular smooth muscle cells dramatically enhances proteoglycan secretion." Circulation, 1994; 90:I—516.
  13. Vijayagopal, P., J. D. Fontenot, J. E. Figueroa and R. G. Lebaron. "Isolation and preliminary characterization of a novel proteoglycan variant from human aorta exhibiting marked affinity for low—density lipoprotein and its enhanced expression in atherosclerotic plaques." Circulation, 1994; 90:I—403.